Document is current

Any future updates will be listed below

Review of the risk of thrombosis or bleeding upon abrupt anagrelide discontinuation in patients with essential thrombocythemia

Crossref DOI link: https://doi.org/10.1007/s00277-022-04956-y

Published Online: 2022-08-17

Published Print: 2022-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark